Svoboda Capital Partners’ investment in 120/80 Health Group signals continued private equity appetite for healthcare services in the middle market, reflecting confidence in the sector’s resilience and growth potential. For credit professionals, this deal underscores the importance of monitoring sponsor-backed healthcare platforms, which often leverage add-ons and operational improvements to drive value. The transaction highlights evolving capital structures and refinancing opportunities in a space where specialized care providers remain attractive targets amid shifting payer dynamics and regulatory pressures.
Svoboda Capital Partners Backs 120/80 Health Group
Source: Private Equity Professional